Efficacy of eplerenone added to candesartan on left ventricular hypertrophy and fibrosis in hypertensive patients
Not Applicable
- Conditions
- hypertension
- Registration Number
- JPRN-UMIN000003657
- Lead Sponsor
- kagawa university hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
over 80 years old AMI,PCI, stroke, hospitalization of heart failure within 6 months valvular disease serum creatinin over 1.5mg/dl in male and over 1.3 in female proteinuria liver cirrosis collagen disease cancer chronic inflammatory disease steroid therapy diuretics therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method left ventricular fibrosis left ventricular diastolic dysfunction left ventricular hypertrophy
- Secondary Outcome Measures
Name Time Method